Literature DB >> 1735780

An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascitic tumours.

R Pannell1, C Milstein.   

Abstract

A simple roller bottle was constructed to house three dialysis tubes, each with a capacity of 75 ml. Cells were grown inside the dialysis tubing, which was immersed in ordinary DMEM medium without serum supplement. Cultures of hybridomas at medium or low density (2 X 10(5) cells/ml) could be expanded directly in the dialysis tubes to attain a high cell density of the order of 10(7)/ml. Continuous gentle stirring of the cells was possible, since the design causes a bubble to oscillate along the length of each tube. The six cell lines tested all gave antibody concentrations of between 1.1 and 2.3 mg/ml at 20 days. Such an in vitro apparatus obviates the need to employ ascites production, because it is as simple or simpler than the injection of mice, and the in vitro product is very rich in antibody, whilst containing low amounts of contaminating proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735780     DOI: 10.1016/0022-1759(92)90046-v

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Antibody buffering of a ligand in vivo.

Authors:  Carol E O'Hear; Jefferson Foote
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

2.  Increase of hybridoma productivity using an original dialysis culture system.

Authors:  B Mathiot; A Perani; D Dumas; M Maugras; J Didelon; J F Stoltz
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

3.  The Super-Spinner: a low cost animal cell culture bioreactor for the CO2 incubator.

Authors:  R Heidemann; U Riese; D Lütkemeyer; H Büntemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Measurement of the absolute number of functioning low-density lipoprotein receptors in vivo using a monoclonal antibody.

Authors:  C Fitzsimmons; R Bush; D Hele; C Godliman; E Gherardi; D E Bowyer
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

5.  Alternative splicing generates secretory isoforms of human CD1.

Authors:  A Woolfson; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

6.  Enhancement of hybridoma formation, clonability and cell proliferation in a nanoparticle-doped aqueous environment.

Authors:  Natalie Gavrilov-Yusim; Ekaterina Hahiashvili; Marina Tashker; Victoria Yavelsky; Ohad Karnieli; Leslie Lobel
Journal:  BMC Biotechnol       Date:  2008-01-14       Impact factor: 2.563

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.